Position in SCLX
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$93
+$14 QoQ
Shares Held
12
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 23 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CoreCap Advisors, LLC holds $42,526,097 across 17 Drug Manufacturers - General names. SCLX ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,921 | $12,170,496 | |
| 2 | MRK |
Merck & Co., Inc.
|
61,485 | $7,900,822 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
46,624 | $5,890,476 | |
| 4 | ABBV |
AbbVie Inc.
|
20,967 | $5,276,135 | |
| 5 | LLY |
ELI LILLY & Co
|
3,816 | $4,577,025 | |
| 6 | AMGN |
Amgen Inc
|
5,755 | $2,084,000 | |
| 7 | PFE |
Pfizer Inc
|
85,905 | $2,068,592 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
24,801 | $1,429,033 |
All Filings in SCLX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93 | 12 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $79 | 12 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $146 | 12 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $236 | 12 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $70 | 12 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||